Europe — EMA

Pageltra (Eltrombopag)

Request sourcing

Pack/s

What is Eltrombopag?

Eltrombopag, the active ingredient in Pageltra, is a thrombopoietin receptor agonist presented as a tablet for oral use. It stimulates platelet production and is used to manage low platelet counts in certain chronic conditions. GNH USA supplies Pageltra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

GNH USA supplies Pageltra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

What is Eltrombopag used for?

Pageltra is an oral thrombopoietin receptor agonist that targets ... .... .... .... ... .

- Chronic Chronic ... ... ... " … ... " … " … " .... . - ... … .... " … " ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →